Liaoning Chengda Biotechnology Co Ltd
SSE:688739

Watchlist Manager
Liaoning Chengda Biotechnology Co Ltd Logo
Liaoning Chengda Biotechnology Co Ltd
SSE:688739
Watchlist
Price: 26.71 CNY -4.02% Market Closed
Market Cap: 4.9B CNY
Have any thoughts about
Liaoning Chengda Biotechnology Co Ltd?
Write Note

Relative Value

The Relative Value of one Liaoning Chengda Biotechnology Co Ltd stock under the Base Case scenario is 49.62 CNY. Compared to the current market price of 26.71 CNY, Liaoning Chengda Biotechnology Co Ltd is Undervalued by 46%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
49.62 CNY
Undervaluation 46%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
66
vs Industry
76
Median 3Y
3.3
Median 5Y
3.3
Industry
7.7
Forward
2.4
vs History
17
vs Industry
10
Median 3Y
10.6
Median 5Y
10.6
Industry
22.7
Forward
14.5
vs History
64
vs Industry
13
Median 3Y
9.3
Median 5Y
9.3
Industry
21.6
vs History
48
vs Industry
4
Median 3Y
46.9
Median 5Y
46.9
Industry
25.2
vs History
79
vs Industry
72
Median 3Y
0.6
Median 5Y
0.6
Industry
2.5
vs History
vs Industry
84
Median 3Y
0
Median 5Y
0
Industry
7.7
Forward
-0.4
vs History
vs Industry
84
Median 3Y
0
Median 5Y
0
Industry
9
vs History
vs Industry
30
Median 3Y
0
Median 5Y
0
Industry
4.2
Forward
-0.7
vs History
vs Industry
28
Median 3Y
0
Median 5Y
0
Industry
4.1
Forward
-0.9
vs History
vs Industry
31
Median 3Y
0
Median 5Y
0
Industry
5.7
vs History
vs Industry
26
Median 3Y
-3.6
Median 5Y
-3.6
Industry
3.6
vs History
vs Industry
74
Median 3Y
0.1
Median 5Y
0.1
Industry
4.6

Multiples Across Competitors

Competitors Multiples
Liaoning Chengda Biotechnology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Liaoning Chengda Biotechnology Co Ltd
SSE:688739
4.9B CNY 2.8 11.8 -1.7 -1.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 888 840.5 -180 080 -218 674.5 -216 179.2
US
Abbvie Inc
NYSE:ABBV
314.7B USD 5.7 61.9 15.4 23.7
US
Amgen Inc
NASDAQ:AMGN
157B USD 4.8 37.1 17.4 32.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.2B USD 4 890.3 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 859.4 -474.5 -516.7 -502.9
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 6 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.9 -54.9 -59 -53.2
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.6 -130.6 -105.1 -76.6
P/E Multiple
Earnings Growth
CN
Liaoning Chengda Biotechnology Co Ltd
SSE:688739
Average P/E: 175.3
11.8
-50%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 080 N/A
US
Abbvie Inc
NYSE:ABBV
61.9
412%
US
Amgen Inc
NASDAQ:AMGN
37.1
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
890.3
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -474.5 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.9 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -130.6 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
Liaoning Chengda Biotechnology Co Ltd
SSE:688739
Average EV/EBITDA: 17.2
Negative Multiple: -1.7
34%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -218 674.5 N/A
US
Abbvie Inc
NYSE:ABBV
15.4
28%
US
Amgen Inc
NASDAQ:AMGN
17.4
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
38%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -516.7 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.1 N/A
EV/EBIT Multiple
EBIT Growth
CN
Liaoning Chengda Biotechnology Co Ltd
SSE:688739
Average EV/EBIT: 22.5
Negative Multiple: -1.7
18%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 179.2 N/A
US
Abbvie Inc
NYSE:ABBV
23.7
88%
US
Amgen Inc
NASDAQ:AMGN
32.9
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -502.9 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.6 N/A

See Also

Discover More
Back to Top